Sbr 1290 Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sbr 1290 Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sbr 1290 Program Today - Breaking & Trending Today

Structure Therapeutics Announces Poster Presentations of its Oral GLP-1 Receptor Agonist GSBR-1290 at the American Diabetes Association 83rd Scientific Sessions

Published: June 8, 2023

Structure Therapeutics announced that clinical and preclinical data from its oral GLP-1 receptor agonist GSBR-1290 program will be presented at the upcoming American Diabetes Association (ADA) 83rd Scientific Sessions

Source: medindia.net

Related Topics:

United StatesSan DiegoXichen LinDan BudwickJun YoonStructure Therapeutics IncExchange CommissionAmerican Diabetes AssociationScientific SessionsChief Scientific OfficerFirst In Human Single Ascending Dose StudyNovel Small MoleculeClinical TherapeuticsStructure TherapeuticsPrivate Securities Litigation Reform ActChief Financial OfficerRal Glp 1 ReceptorSbr 1290 ProgramAmerican Diabetes Association3rd Scientific SessionsEalth Press Release